Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients

Power Life Sciences Inc.500 enrolled

Overview

Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. This data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future rheumatoid arthritis patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Rheumatoid Arthritis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has been diagnosed with rheumatoid arthritis * Patient has self-identified as planning to enroll in an interventional clinical trial * Patient is 18 years old Exclusion Criteria: * ECOG score of 4 * Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Patient decides to enroll in clinical trial

Time frame: 3 Months

Patient remains in clinical trial to completion

Time frame: 12 months